Table 2.
Pathological type | Case no. | Ki-67 LI** (%) | MVD*** (per HPF) | MMP-2 expression* | MMP-9 expression* |
---|---|---|---|---|---|
Luminal | 2 | 5.59 | 18.3 | − | − |
7 | 6.25 | 29.6 | + | + | |
8 | 0.6 | 21.3 | + | − | |
10 | 2.33 | 32.3 | − | − | |
12 | 1.95 | 31.6 | + | + | |
16 | 1.45 | 21 | + | + | |
| |||||
Intraluminal | 3 | 3.95 | 36.3 | ++ | ++ |
4 | 6.2 | 37.3 | ++ | ++ | |
6 | 1.85 | 42.3 | ++ | ++ | |
9 | 4.56 | 20.3 | ++ | ++ | |
17 | 2.85 | 47.3 | ++ | ++ | |
18 | 5.97 | 21 | ++ | ++ | |
| |||||
Mural | 1 | 9.13 | 52 | ++ | ++ |
5 | 4.78 | 47 | +++ | +++ | |
11 | 2.72 | 22 | +++ | ++ | |
13 | 4.43 | 54 | +++ | +++ | |
14 | 3.08 | 37 | +++ | +++ | |
15 | 3.65 | 39 | +++ | +++ |
*Immunohistochemical reactivity for MMP-2 and MMP-9: (−) negative, (+) weak positive, (++) moderate positive, and (+++) strong positive.
**Ki-67 LI: Ki-67 labeling index.
***MVD: microvessel density.